(1)
Andrey Emanuilov Manov, Ashan Thomas Hatharasinghe & Katrina Equinox Lopez. Comparison of the Effect on Hyperglycemia and the Adverse Effects Among Different GLP-1 Receptor Agonists Added to Basal Insulin and Between GLP-1 Receptor Agonists and Basal Insulin Versus Basal-Plus or Basal-Bolus Insulin in Type 2 Diabetes: A Meta-Analysis. NFMMR-V10 2021, 147-163.